The Story Of Our Firm | En Français | En Español
 Home    Lawyers   Litigation   Choose Us   Settlements   Search
FONT SIZE: A A A A A

Previous Investigations Other Litigations ADHD Drugs Research Center

Adderall Research

in this section: Adderall Research | Adderall Side Effects | Adderall - Types and Active Ingredients | Ritalin Research | Ritalin Side Effects

Bookmark This Page Print This Page Email This Page

Adderall Lawsuit Information: Learn More about Adderall

Adderall® CII is a pharmaceutical amphetamine used to treat attention-deficit hyperactivity disorder and narcolepsy. It was first prescribed in the 1970s as an anorectic (under the brand name Obetrol®), but such usage is now rare.

Adderall is a central nervous system stimulant composed of four amphetamine salts: amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate (the last salt is also prescribed alone as Dexedrine®). The four component salts are claimed to be metabolised at different rates.

The average elimination half-life for dextroamphetamine is 10 hours in adults, and for levoamphetamine, 13 hours. Its effects are otherwise similar to other central nervous system stimulants.

The manufacturer claims that the mixture of salts makes Adderall's effects smoother, with softer highs and lows, than those of other treatments for the same disorders.

There is little evidence, however, to support this claim for immediate-release Adderall. A recent patent application for Adderall (USP #6,384,020) was a pharmaceutical composition patent listing a rapid immediate release oral dosage form. No claim of increased or smooth drug delivery was made. A recent double-blind, placebo-controlled crossover study, conducted among children, indicated that Adderall behaved similarly to other immediate release amphetamines. The authors found that sustained-release dexamphetamine (the main isomeric-amphetamine component of Adderall) had a longer duration of action, and cost less than Adderall, though dexamphetamine was less effective in the first few hours of morning dosing.

Adderall is now sold in either an immediate-release tablet or an extended-release capsule, marketed as Adderall XR. Doses for both immediate-release and extended-release form come in 5mg, 10mg, 15mg, 20mg, 25mg, and 30mg increments.

Adderall XR utilizes the Microtrol® delivery system to achieve the extended-release mechanism. This delivery system incorporates two beads: the first type of bead dissolves immediately and the second type releases four hours later. Maximum plasma concentration is achieved in seven hours, compared to regular Adderall IR (immediate-release) which reaches maximum plasma concentration within three hours. As a result of its high bioavailability, Adderall XR's effectiveness is not altered by food absorption in the GI tract. However, tmax (mean plasma concentration) is prolonged by 2.5 hours (using a standard high-fat meal as the control). Acidic beverages should not be taken with Adderall XR as they alter the pH balance of the stomach.

Adderall is manufactured by Catalytica Pharmaceuticals Inc. of Greenville, North Carolina and is distributed by Shire Pharmaceuticals. Generic equivalents (known to pharmacists as "amphetamine salts," "mixed amphetamines," or simply "amphetamines," inter alia) are also distributed in the United States by Mallinckrodt Pharmaceuticals and Ranbaxy Laboratories.

Weitz & Luxenberg is no longer accepting ADHD drug cases.


see also:

Adderall Side Effects Adderall Side Effects - Information from Adderall ADHD Attorneys
Learn about Dangerous Adderall Side Effects - Info from ADHD Attorneys

Ritalin Research Ritalin Lawsuit Information - Learn about Ritalin (Methylphenidate)
Learn about the Dangers of Ritalin Methylphenidate - FREE Lawsuit Info

Learn More ADHD Lawsuit - Learn about ADHD Drugs and their Dangerous side effects
FREE Lawsuit Info- Learn about ADHD drugs, including Adderall, Ritalin

Name Phone Email
Do you have a legal question? Ask us!   strictly confidential
Your Question
Free Legal Review
Name:
Phone:
Email:
Case Description:
$423 million settlement— MTBE suit involving the contamination of 153 public water systems nationally

$16.5 million verdict — Asbestos case involving exposure from dental tape

$1.4 million settlement — Accident involving woman struck down by ambulance

$1.5 million settlement — for 47-year-old construction worker who fell off elevated train tracks

$6 million settlement — Pediatric malpractice involving infant who suffered brain damage at birth

$53 million verdict — brake mechanic suffering from mesothelioma

$13.5 million verdict — one of the very first Vioxx trial cases

$15 million settlement — man wound up a paraplegic due to negligent hospital care

$37 million verdict — 2 asbestos lung cancer plaintiffs

$47 million verdict — boilermaker who died from mesothelioma

$2.6 million settlement — ill-fitting prosthesis caused decubitus ulcers

$75 million verdict — historic consolidated trial involving men who had worked at the Brooklyn Navy Yard in the 1940s and 1950s

$12.7 million verdict — iron worker who was injured due to unsafe working conditions

$8 million settlement — obstetrical malpractice resulted in neurological deficits

$64.65 million award — 4 asbestos plaintiffs

$17.5 million — consolidated trial of 5 mesothelioma victims


Ask a Free Question:
Were you injured?

check for your response [login]
For legal help anywhere in the U.S.
A nationally-recognized personal injury law firm, Weitz & Luxenberg is committed to helping clients win cases, get the compensation to which they’re entitled and continue with their lives. In just over 20 years, we’ve collected more than $1.3 billion for plaintiffs.